Isolation of VIM-2-producing Pseudomonas monteilii clinical strains disseminated in a tertiary hospital in northern Spain

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 2, 2015, Pages 1334-1336

  Ocampo Sosa, Alain A ^a   Guzmán Gómez, Laura P ^a   Fernández Martínez, Marta ^a   Román, Elena ^a   Rodríguez, Cristina ^a   Marco, Francesc ^b   Vila, Jordi ^b   Martínez Martínez, Luis ^a,c  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PROTEIN VIM 2; TOBRAMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; GRAM NEGATIVE AEROBIC RODS AND COCCI; INTEGRON; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS MONTEILII; PSEUDOMONAS PUTIDA; RESERVOIR; SPAIN; TERTIARY CARE CENTER; DRUG EFFECTS; ENZYMOLOGY; HUMAN; METABOLISM; PSEUDOMONAS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; HUMANS; PSEUDOMONAS; SPAIN; TERTIARY CARE CENTERS;

EID: 84921796606     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.04639-14     Document Type: Article

References (22)

1. Walsh TR, Toleman MA, Poirel L, Nordmann P. 2005. Metallo-betalactamases: the quiet before the storm? Clin Microbiol Rev 18:306-325. http://dx.doi.org/10.1128/CMR.18.2.306-325.2005.
2. Walsh TR. 2010. Emerging carbapenemases: a global perspective. Int J Antimicrob Agents 36(Suppl 3):S8 -S14. http://dx.doi.org/10.1016/S0924 -8579(10)70004-2.
3. Cornaglia G, Giamarellou H, Rossolini GM. 2011. Metallo-β-lactamases: a last frontier for β-lactams? Lancet Infect Dis 11:381-393. http://dx.doi.org/10 .1016/S1473-3099(11)70056-1.
4. Yong D, Toleman MA, Bell J, Ritchie B, Pratt R, Ryley H, Walsh TR. 2012. Genetic and biochemical characterization of an acquired subgroup B3 metallo-β-lactamase gene, blaAIM-1, and its unique genetic context in Pseudomonas aeruginosa from Australia. Antimicrob Agents Chemother 56:6154-6159. http://dx.doi.org/10.1128/AAC.05654-11.
5. Leiros HK, Borra PS, Brandsdal BO, Edvardsen KS, Spencer J, Walsh TR, Samuelsen ∅. 2012. Crystal structure of the mobile metallo-β - lactamase AIM-1 from Pseudomonas aeruginosa: insights into antibiotic binding and the role of Gln157. Antimicrob Agents Chemother 56:4341- 4353. http://dx.doi.org/10.1128/AAC.00448-12.
6. Pollini S, Maradei S, Pecile P, Olivo G, Luzzaro F, Docquier JD, Rossolini GM. 2013. FIM-1, a new acquired metallo-β-lactamase from a Pseudomonas aeruginosa clinical isolate from Italy. Antimicrob Agents Chemother 57:410-416. http://dx.doi.org/10.1128/AAC.01953-12.
7. Docquier JD, Lamotte-Brasseur J, Galleni M, Amicosante G, Frére JM, Rossolini GM. 2003. On functional and structural heterogeneity of VIMtype metallo-β-lactamases. J Antimicrob Chemother 51:257-266. http: //dx.doi.org/10.1093/jac/dkg067.
8. Juan Nicolau C, Oliver A. 2010. Carbapenemases in Pseudomonas spp. Enferm Infecc Microbiol Clin 28:19-28. (In Spanish.) http://dx.doi.org /10.1016/S0213-005X(10)70004-5.
9. Elomari M, Coroler L, Verhille S, Izard D, Leclerc H. 1997. Pseudomonas monteilii sp. nov., isolated from clinical specimens. Int J Syst Bacteriol 47:846-852.
10. Scotta C, Juan C, Cabot G, Oliver A, Lalucat J, Bennasar A, Albertí S. 2011. Environmental microbiota represents a natural reservoir for dissemination of clinically relevant metallo-β-lactamases. Antimicrob Agents Chemother 55: 5376-5379. http://dx.doi.org/10.1128/AAC.00716-11.
11. Bogaerts P, Bouchahrouf W, Lissoir B, Denis O, Glupczynski Y. 2011. IMP-13-producing Pseudomonas monteilii recovered in a hospital environment. J Antimicrob Chemother 66:2434-2440. http://dx.doi.org/10 .1093/jac/dkr294.
12. Mulet M, Lalucat J, García-Valdés E. 2010. DNA sequence-based analysis of the Pseudomonas species. Environ Microbiol 12:1513-1530.
13. st ed. Approved document M100- S21. Clinical and Laboratory Standards Institute, Wayne, PA.
14. Gutiérrez O, Juan C, Cercenado E, Navarro F, Bouza E, Coll P, Pérez JL, Oliver A. 2007. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob Agents Chemother 51:4329-4335. http://dx.doi.org/10 .1128/AAC.00810-07.
15. Dubois V, Arpin C, Dupart V, Scavelli A, Coulange L, André C, Fisher I, Grobost F, Brochet JP, Lagrange I, Dutilh B, Jullin J, Noury P, Larribet G, Quentin C. 2008. Beta-lactam and aminoglycoside resistance rates and mechanisms among of Pseudomonas aeruginosa in French general practice (community and private healthcare centres). J Antimicrob Chemother 62:316-323. http://dx.doi.org/10.1093/jac/dkn174.
16. Miro E, Grünbaum F, Gómez L, Rivera A, Mirelis B, Coll P, Navarro F. 2013. Characterization of aminoglycoside-modifying enzymes in Enterobacteriaceae clinical strains and characterization of the plasmids implicated in their diffusion. Microb Drug Resist 19:94-99. http://dx.doi.org /10.1089/mdr.2012.0125.
17. Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. 2006. Prevalence in the United States of aac (6=) - Ib-cr encoding a ciprofloxacinmodifying enzyme. Antimicrob Agents Chemother 50:3953-3955. http: //dx.doi.org/10.1128/AAC.00915-06.
18. Mazel D, Dychinco B, Webb VA, Davies J. 2000. Antibiotic resistance in the ECOR collection: integrons and identification of a novel aad gene. Antimicrob Agents Chemother 44:1568-1574. http://dx.doi.org/10.1128 /AAC.44.6.1568-1574.2000.
19. Ruiz E, Ocampo-Sosa AA, Alcoba-Flórez J, Román E, Arlet G, Torres C, Martínez-Martínez L. 2012. Changes in ciprofloxacin resistance levels in Enterobacter aerogenes isolates with variable expression of the aac(6=)-Ib-cr gene. Antimicrob Agents Chemother 56:1097-1100. http://dx.doi.org/10 .1128/AAC.05074-11.
20. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. 2005. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 63:219-228. http://dx.doi.org/10.1016/j.mimet.2005.03.018.
21. Römling U, Tümmler B. 2000. Achieving 100% typeability of Pseudomonas aeruginosa by pulsed-field gel electrophoresis. J Clin Microbiol 38: 464-465.
22. Ma Q, Qu Y, Tang H, Yu H, Ma F, Shi S, Zhang X, Zhou H, Zhou J, Xu P. 2012. Genome sequence of a novel indigo-producing strain, Pseudomonas monteilii QM. J Bacteriol 194:4459-4460. http://dx.doi.org/10 .1128/JB.00867-12.